Cybin Irl Limited
Clinical trials sponsored by Cybin Irl Limited, explained in plain language.
-
Magic Mushroom-Derived drug enters final trial for depression
Symptom relief Recruiting nowThis Phase 3 study tests whether CYB003, a psilocin analog (related to the active ingredient in magic mushrooms), can safely reduce depression symptoms in 330 adults with major depressive disorder. Participants receive either one of two doses of CYB003 or a placebo, along with ps…
Phase: PHASE3 • Sponsor: Cybin IRL Limited • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New depression pill CYB003 enters final testing phase
Symptom relief Recruiting nowThis study tests an experimental oral drug called CYB003 in 220 adults with major depressive disorder. Participants receive either CYB003 or a placebo alongside their usual treatment. The goal is to see if CYB003 safely reduces depression symptoms better than placebo.
Phase: PHASE3 • Sponsor: Cybin IRL Limited • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC